title: Overexpression of phospholipase D prevents actinomycin D-induced apoptosis through potentiation of phosphoinositide 3-kinase signalling pathways in Chinese-hamster ovary cells.
abstract: To examine the roles of PLD (phospholipase D) in the regulation of the apoptotic process, PLD1 and PLD2 were stably overexpressed in S1P3-CHO cells [CHO (Chinese-hamster ovary) cells expressing the S1P (sphingosine 1-phosphate) receptor S1P3]. Treatment of S1P3-CHO cells with ActD (actinomycin D) induced apoptosis, as shown by the occurrence of nuclear fragmentation and the caspase-dependent proteolytic cleavage of PARP [poly(ADP-ribose) polymerase] and protein kinase Cd. Overexpression of either PLD1 or PLD2 protected S1P3-CHO cells from ActD-induced apoptosis, as demonstrated by an increased number of viable cells and inhibition of PARP and protein kinase Cd cleavage. However, in the early phase of apoptosis, ActD induced an increase in PLD activity and activation of key factors in the cell-survival signalling pathways, such as PI3K (phosphoinositide 3-kinase), Akt, p70S6K (p70 S6 kinase) and ERK (extracellular-signal-regulated kinase). Furthermore, the ActD-induced activation of these survival signalling enzymes was potentiated by overexpression of either PLD1 or PLD2. The PI3K inhibitor LY294002 inhibited the ActD-induced activation of Akt and p70S6K, and completely abolished the effects of PLD1 or PLD2, whereas inhibition of ERK activity by the MEK inhibitor U0126 had a milder effect. The ActD-induced activation of p70S6K and ERKs was blocked by 1-butanol, but not by t-butanol; similar to S1P, exogenous PLD suppressed the ActD-induced events in the apoptosis signalling pathways. These results show that, in S1P3-CHO cells, increased expression of PLDs prevents ActD-induced apoptosis by enhanced activation of the PI3K signalling pathways.
authors.affiliation: Department of Biochemistry, Gifu Pharmaceutical University, Mitahora, Gifu, Japan.
authors.forename: Momoko
authors.initials: M
authors.lastname: Yamada
authors.forename: Yoshiko
authors.initials: Y
authors.lastname: Banno
authors.forename: Yoh
authors.initials: Y
authors.lastname: Takuwa
authors.forename: Masahiro
authors.initials: M
authors.lastname: Koda
authors.forename: Akira
authors.initials: A
authors.lastname: Hara
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Nozawa
mesh_terms: D000818:Animals; D017209:Apoptosis; D016466:CHO Cells; D002470:Cell Survival; D006224:Cricetinae; D003609:Dactinomycin / Q000037:antagonists & inhibitors* / Q000633:toxicity; D015870:Gene Expression; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D010739:Phospholipase D / Q000235:genetics / Q000378:metabolism* / Q000502:physiology; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D049312:Receptors, Lysophospholipid; D015398:Signal Transduction; D014162:Transfection
chemical_list: D043562:Receptors, G-Protein-Coupled; D049312:Receptors, Lysophospholipid; D003609:Dactinomycin; D019869:Phosphatidylinositol 3-Kinases; C105606:phospholipase D2; D010739:Phospholipase D; C106801:phospholipase D1